IP Library Granted Patent US 10,328,107
Granted Patent B2
US 10,328,107 · App. 16/100,590 · Granted Jun 25, 2019

Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

Inventor: Thomas Julius Borody (Five Dock, AU)
Assignee: Crestovo Holdings LLC
A61K35/74A61K9/4891A61K35/24A61K35/742A61M5/142A61P1/12C12N1/00A61K9/4875A61K2035/115A61M31/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,328,107
App. No.
16/100,590
Granted
Jun 25, 2019
Kind
B2
Abstract

In alternative embodiments, the invention provides compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments or lavage, e.g., orthostatic lavage, e.g., for inducing the purgation (e.g., cleansing) of a gastrointestinal (GI) tract, including a colon; and methods for making and using them. In alternative embodiments, compositions and methods of the invention are used for the stabilization, amelioration, treatment and/or prevention of constipation, for the treatment of abdominal pain, particularly non-specific abdominal pain, and diarrhea, including diarrhea caused by a drug side effect, a psychological condition, a disease or a condition such as Crohn's Disease, a poison, a toxin or an infection, e.g., a toxin-mediated travelers diarrhea, or C. difficile or the pseudo-membranous colitis associated with this infection. In alternative embodiments, the invention provides pharmaceuticals and products (articles) of manufacture for delivering these compositions and formulations to an individual, e.g., a human or an animal. The invention also provides devices for delivering a fecal material to a patient.

Claims (33)

1. A method comprising:

receiving at a central location a non-frozen stool sample from a donor, wherein the stool sample is within a stool collection device;

testing the stool sample for pathogens;

mixing the stool sample with a cryoprotectant to form a mixture; and

homogenizing the mixture to produce a composition comprising viable bacteria from the stool sample.

2. The method of claim 1 , wherein the method further comprises filtering the composition to produce a filtrate.

3. The method of claim 2 , wherein the method further comprises selectively removing bacteria from the filtrate to produce a composition comprising bacterial species of the phylum Firmicutes.

4. The method of claim 3 , wherein the selectively removed bacteria comprise Bacteroides.

5. The method of claim 3 , wherein the composition comprises a bacterial population consisting essentially of bacterial species of the phylum Firmicutes.

6. The method of claim 2 , wherein the method further comprises lyophilizing the filtrate.

7. The method of claim 6 , wherein the method further comprises encapsulating the lyophilized filtrate into a carrier.

8. The method of claim 7 , wherein the encapsulated filtrate is in a graded release capsule.

9. The method of claim 6 , wherein the method further comprises sending the lyophilized filtrate to a remote location.

10. The method of claim 2 , wherein the stool sample is maintained below room temperature.

11. The method of claim 2 , wherein the filtering separates bacteria from microscopic fiber.

12. The method of claim 2 , wherein the filtering separates bacteria from rough particulate matter.

13. The method of claim 1 , wherein the cryoprotectant comprises trehalose.

14. The method of claim 1 , wherein said mixing further comprises mixing the stool sample with an antioxidant.

15. The method of claim 1 , wherein said mixing further comprises mixing the stool sample with cysteine.

16. The method of claim 1 , wherein an interior of the stool collection device is anaerobic.

17. A method comprising:

receiving at a central location a non-frozen stool sample from a donor, wherein the stool sample is within a stool collection device, and wherein the donor has been prescreened for infectious agents;

mixing the stool sample with a liquid to form mixture, wherein the liquid comprises a cryoprotectant; and

homogenizing the mixture to produce a composition comprising viable bacteria from the stool sample.

18. The method of claim 17 , wherein the method further comprises filtering the composition to produce a filtrate.

19. The method of claim 18 , wherein the method further comprises selectively removing bacteria from the filtrate to produce a composition comprising bacterial species of the phylum Firmicutes.

20. The method of claim 18 , wherein the method further comprises lyophilizing the filtrate.

21. The method of claim 20 , wherein the method further comprises encapsulating the lyophilized filtrate into a carrier.

22. The method of claim 20 , wherein the method further comprises sending the lyophilized filtrate to a remote location.

23. The method of claim 18 , wherein the stool sample is maintained below room temperature.

24. The method of claim 18 , wherein the filtering separates bacteria from microscopic fiber.

25. The method of claim 18 , wherein the filtering separates bacteria from rough particulate matter.

26. The method of claim 17 , wherein an interior of the stool collection device is anaerobic.

Assignments (5)
CHANGE OF NAME Recorded Dec 31, 2020
From: CRESTOVO HOLDINGS LLC
To: FINCH THERAPEUTICS HOLDINGS LLC
Reel/Frame 054883/0280 →
RELEASE OF SECURITY INTEREST Recorded Sep 5, 2019
From: CRESTOVO INVESTOR LLC; M3 VENTURES - FINCH II LLC; AVENIR FINCH INVESTORS LLC; FLIGHT PARTNERS MANAGEMENT LLC; NATIONAL PHILANTHROPIC TRUST; 91313 INVESTMENT HOLDING I LLC; SILAS HOLDING I LLC; BEE HILL HOLDINGS LLC; GORMAN, DYLAN; CHOI, KENNETH S.
To: CRESTOVO HOLDINGS LLC
Reel/Frame 050274/0530 →
SECURITY INTEREST Recorded Mar 7, 2019
From: CRESTOVO HOLDINGS LLC
To: CRESTOVO INVESTOR LLC; M3 VENTURES - FINCH II LLC; AVENIR FINCH INVESTORS, LLC; FLIGHT PARTNERS MANAGEMENT LLC; NATIONAL PHILANTHROPIC TRUST; 91313 INVESTMENT HOLDINGS LLC; SILAS HOLDINGS LLC; BEE HILL HOLDINGS LLC; GORMAN, DYLAN; CHOI, KENNETH S.
Reel/Frame 050111/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2018
From: BORODY, THOMAS J.
To: CRESTOVO LLC
Reel/Frame 046617/0603 →
CONFIRMATORY ASSIGNMENT Recorded Aug 10, 2018
From: CRESTOVO LLC
To: CRESTOVO HOLDINGS LLC
Reel/Frame 046763/0415 →
Priority Claims (1)
AU 2010903474 · Aug 4, 2010 · national
Continuity (10)
Continuation 15975456 · May 9, 2018
Continuation 15950939 · Apr 11, 2018
Continuation 15782519 · Oct 12, 2017
Continuation 15093679 · Apr 7, 2016
Continuation 13813915
Provisional Application 61494363 · Jun 7, 2011
Provisional Application 61483487 · May 6, 2011
Provisional Application 61451087 · Mar 9, 2011
Provisional Application 61450099 · Mar 7, 2011
Related Publication 20190015462A1 · Jan 17, 2019
Cited By (2)
US 12,290,538 US 12,409,085